Combined-modality therapy for gastric cancer
- PMID: 14648779
- DOI: 10.1002/ssu.10040
Combined-modality therapy for gastric cancer
Abstract
Gastric cancer has a poor prognosis. It is often diagnosed at an advanced stage, and potentially curative treatments often can not be exercised. Even when a curative surgical resection is possible, only a minority of patients survive beyond 5 years, and locoregional failures are frequent among patients undergoing curative resections. Recently, the use of postoperative adjuvant chemoradiotherapy has yielded some notable benefits. Earlier studies have shown survival benefits in patients undergoing chemoradiotherapy for locally advanced unresectable gastric cancer. The recently reported Intergroup 0116 trial compared surgery alone with surgery plus postoperative chemotherapy plus chemoradiotherapy. Superior overall and disease-free survival rates among patients given combined-modality postoperative therapy were observed. These results established a new standard of care for patients following resection of gastric carcinoma. Preoperative combined-modality chemoradiotherapy may improve resectability, and is under investigation at the University of Texas M. D. Anderson Cancer Center. The development of novel radioenhancers and the selection of therapy on the basis of molecular determinants of response may result in much-needed advances in this field.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
[Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma].Chirurg. 2002 Apr;73(4):325-30. doi: 10.1007/s00104-002-0459-8. Chirurg. 2002. PMID: 12063916 German.
-
Adjuvant therapy in gastric cancer.J Clin Oncol. 2005 Sep 1;23(25):6220-32. doi: 10.1200/JCO.2005.11.593. J Clin Oncol. 2005. PMID: 16135489 Review.
-
[Utilization of multimodal therapy concepts in stomach carcinoma in Germany].Zentralbl Chir. 2000;125(4):341-7. Zentralbl Chir. 2000. PMID: 10829314 German.
-
The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.Best Pract Res Clin Gastroenterol. 2007;21(6):965-81. doi: 10.1016/j.bpg.2007.10.003. Best Pract Res Clin Gastroenterol. 2007. PMID: 18070698 Review.
-
The role of irradiation as a component of combined modality treatment for gastric cancer.J Infus Chemother. 1995 Summer;5(3):117-24. J Infus Chemother. 1995. PMID: 8528968 Review.
Cited by
-
Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience.Ann Surg Oncol. 2021 Feb;28(2):758-765. doi: 10.1245/s10434-020-08864-1. Epub 2020 Jul 21. Ann Surg Oncol. 2021. PMID: 32696305 Free PMC article.
-
Progress of preoperative and postoperative radiotherapy in gastric cancer.World J Surg Oncol. 2018 Sep 13;16(1):187. doi: 10.1186/s12957-018-1490-7. World J Surg Oncol. 2018. PMID: 30213266 Free PMC article. Review.
-
Melanoma differentiation-associated gene-7 suppresses human gastric cancer cell invasion and migration.Oncol Lett. 2017 Dec;14(6):7139-7144. doi: 10.3892/ol.2017.7086. Epub 2017 Sep 27. Oncol Lett. 2017. PMID: 29344144 Free PMC article.
-
Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?World J Gastroenterol. 2016 Jan 21;22(3):1131-8. doi: 10.3748/wjg.v22.i3.1131. World J Gastroenterol. 2016. PMID: 26811652 Free PMC article. Review.
-
Effect of gastrectomy with bursectomy on prognosis of gastric cancer: a meta-analysis.World J Gastroenterol. 2014 Oct 28;20(40):14986-91. doi: 10.3748/wjg.v20.i40.14986. World J Gastroenterol. 2014. PMID: 25356060 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical